<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04562857</url>
  </required_header>
  <id_info>
    <org_study_id>AF and sleep apnea</org_study_id>
    <nct_id>NCT04562857</nct_id>
  </id_info>
  <brief_title>Effects of Exercise Training in Patients With Atrial Fibrillation and Sleep Apnea: A Pilot Study</brief_title>
  <official_title>Effects of Exercise Training in Patients With Atrial Fibrillation and Sleep Apnea: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swinburne University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: There are still many gaps in research concerning the effect of different physical&#xD;
      training modalities on sleep deprivation in the population with different types of sleep&#xD;
      apnea. Aims: The purpose of this study was to examine the effect of moderate-intensity&#xD;
      interval training (MITT) on patients with different types of sleep apnea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: 15 Participants aged 45-65 years were randomized into two groups: obstructive sleep&#xD;
      apnea group (OSA), and central sleep apnea group (CSA). The training lasted ten consecutive&#xD;
      weeks with 30 uninterrupted sessions. The actigraph together with the Pittsburg sleep quality&#xD;
      index (PSQI) was used in sleep quality assessment. The actigraph (Actiwatch Minimitter&#xD;
      Company, Incorporated (INC) - Sunriver, OR, USA) was placed on the non-dominant wrist and&#xD;
      activities were monitored continuously while being recorded at one-minute intervals. The&#xD;
      participants kept the device for a period of 96 hours, filled PSQI, and did 6MWT before the&#xD;
      first and last training sessions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 10, 2019</completion_date>
  <primary_completion_date type="Actual">December 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep quality scores (0 is best, 3 is worst)</measure>
    <time_frame>10 weeks</time_frame>
    <description>data about sleep from Pittsburgh sleep quality index questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sleep latency (in min)</measure>
    <time_frame>10 weeks</time_frame>
    <description>time spent in bed before falling asleep (from the actigraph)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total sleep time (in hours)</measure>
    <time_frame>10 weeks</time_frame>
    <description>Total time actually slept (from the actigraph)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep fragmentation index (in %) (the more means worse)</measure>
    <time_frame>10 weeks</time_frame>
    <description>Index of the level of the sleep continuity (from the actigraph)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cutpoints</measure>
    <time_frame>10 weeks</time_frame>
    <description>numbers displayed on the actigraph to give a picture about activity level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>six minute walking distance (in meters)</measure>
    <time_frame>10 weeks</time_frame>
    <description>represent aerobic capacity (distance walked in 6 min)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Sleep Deprivation</condition>
  <arm_group>
    <arm_group_label>obstructive sleep apnea</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>interval exercises (intervention) on bicycle for patients with AF and OSA for 10 weeks, 3 times/week for duration of 30-45 min/ session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Central sleep apnea</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>interval exercises (intervention) on bicycle for patients with AF and CSA for 10 weeks, 3 times/week for duration of 30-45 min/ session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Moderate intensity interval training (MITT)</intervention_name>
    <description>interval exercises (intervention) on bicycle for patients with AF and OSA or AF with CSA for 10 weeks, 3 times/week for duration of 30-45 min/ session.</description>
    <arm_group_label>Central sleep apnea</arm_group_label>
    <arm_group_label>obstructive sleep apnea</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who have AF confirmed by ECG&#xD;
&#xD;
          2. Their ages range from 45 and 65 years of age&#xD;
&#xD;
          3. Medically stable patients.&#xD;
&#xD;
          4. Current complaint of poor Sleep quality (SQ) (score &gt; 5 of the SQ scale)&#xD;
&#xD;
          5. Patients who have OSA or CSA confirmed by polysomnography&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any patient was known to have any unstable medical condition;or with any known&#xD;
             musculoskeletal or neurological conditions that might interfere with the execution or&#xD;
             the assessment of the exercise, was excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hady Balabel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National heart institute</name>
      <address>
        <city>Giza</city>
        <state>Cairo</state>
        <zip>11262</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Hady Atef Labib</investigator_full_name>
    <investigator_title>Lecturer of physical therapy for cardiopulmonary disorders, Faculty of Physical therapy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Deprivation</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>After approval can be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>after 1 month for12 months</ipd_time_frame>
    <ipd_access_criteria>will upload it to the journal of publication</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT04562857/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

